Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II

NCT02911935 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02911935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02911935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II
Lead sponsor
Washington University School of Medicine
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2016
Completion date
April 30, 2021
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus, bronchiolitis